/
Login
Analysis Scores
Damodaran ?
45/100
Dalio Risk ?
98/100
Piotroski ?
6/9
Neutral
Graham ?
$49.6
Pahalı
Active Metric?
4/4
Confidence?
75%
Valuation
Potential?
-44.0%
ROIC ?
29.9%
DCF Value ?
56.86
Debt Cycle?
Early Expansion
Data
Data ?
13498
1973-02-21 → 2026-09-03
Risk Analysis (VaR)
Çok Yüksek
252 days
Annual Volatility ?
%75.5
VaR 95% ?
%7.29
daily max loss
VaR 99% ?
%10.53
daily max loss
CVaR 95% ?
%10.22
expected loss (tail)
Max Drawdown ?
%33.7
30.06.2026 → 28.07.2026
Skewness ?
0.01
Parametrik%7.29
Historik%6.57
Cornish-Fisher%7.03
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (341.62), TRAMA-99 line's %9.3 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 341.62
TRAMA: 376.5319
Difference: %-9.3
Profitability
Net Profit Margin
%31.1
Net profit margin %31.1 — very strong. Compared to previous quarter +7.4 point increase.
ROE – Özkaynak Getirisi (TTM)
%26.1
ROE %26.1 — high return on equity.
EBITDA Margin
%39.1
EBITDA margin %39.1 — operationally very efficient.
Gross Profit Margin
%60.9
Gross profit per revenue %60.9. Strong pricing power.
Free Cash Flow Margin (TTM)
%14.6
TTM Free Cash Flow is %14.6'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio
63.3x
Sector: 32.7x
F/K 63.3x — sector median's (32.7x) %94 above. Expensive zone.
P/B Ratio
17.19x
Sector: 4.59x
PD/DD 17.19x — sector median's %274 above. Expensive book value.
EV/EBITDA
47.3x
Sector: 21.8x
EV/EBITDA 47.3x — sector median's (21.8x) %116 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio
2.15x
Current ratio 2.15x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
0.1x
Net Borç/EBITDA 0.1x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.03x
Low leverage — majority of assets financed by equity.
Interest Coverage
123.8x
Interest coverage 123.8x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY)
%+87.0
Revenue YoY %87.0 grew (2026/3) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY)
%+303.4
Net profit YoY %303.4 increased (2026/3) — extraordinary profit growth.
Score Explanations
Lothien Robustness
42/100
Moderate robustness (42/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-44.0%
Minus %44.0 expected value (193.42) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %75.
Components: PE target: 231.79 | P/B target: 102.03 | EV/EBITDA target: 159.66 | DCF target: 86.41
Damodaran Valuation
45/100
Low Damodaran score (45/100). DCF analysis does not support current price.
Weak
Dalio Risk Analysis
98/100
Low debt risk (98/100). Interest coverage ratio 123.8x — strong. Borç/EBITDA 0.1x — in healthy range.
Leverage: 99/100 | Debt Service: 100/100 | Quality: 93/100
ROIC – Sermaye Getirisi
%29.9
ROIC (%29.9) cost of capital 19.0 puan aşıyor → company creates value.
WACC: %10.9
DCF Discounted Cash Flow
56.86
DCF (56.86) current price %83.5 below — cash flows do not support current price.
Current price: 345.62
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
6/9
Moderate Piotroski (6/9). Some balance sheet criteria met, some missing.
Neutral
Graham Intrinsic Value
$49.6
Güncel fiyat Graham valuenin %85.6 üzerinde ($49.6) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/E Ratio
63.3x
vs 32.7x
Sector mediannın %94 above — expensive
P/B Ratio
17.19x
vs 4.59x
Compared to sector %274 more expensive (by book value)
EV/EBITDA
47.3x
vs 21.8x
Compared to sector %116 higher EV/EBITDA
ROIC vs WACC
%29.9
vs %10.9 WACC
ROIC 19.0 baz puan exceeds cost of capital
Net Profit Margin (TTM)
%22.6
vs %30.1 EBITDA margin
TTM net profit margin %22.6
Charts
Indicators
BB deviation
?
RSI thresholds
?
▲ içeriden alım ·
▼ içeriden satım ·
★ katalizör (haber-sezgisel) ·
■ 13D aktivist ·
■ 13G pasif
— SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
İçeriden Alım-Satım Akışı
Kim aldı, kim sattı, ne kadar
TER — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.